CXCL3 Antibody 500-P105-1MG from Thermo Fisher Scientific | Biocompare.com

Supplier Images

CXCL3 Antibody

Western Blot: To detect Human GRO-gamma (CXCL3) by Western Blot analysis CXCL3 Polyclonal Antibody (Product # 500-P105-1MG) can be used at a concentration of 0.1-0.2 µg/mL. When used in conjunction with compatible secondary reagents, the detection limit for Recombinant Human GRO-gamma (CXCL3) is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
CXCL3 Antibody

The CXCL3 Antibody from Thermo Fisher Scientific is a Rabbit Polyclonal antibody to CXCL3. This antibody recognizes Homo Sapiens, and Human antigen. The CXCL3 Antibody has been shown to work in the following applications: EIA, Immunoassay, ELISA, and Western Blot.

Product Specs
ItemCXCL3 Antibody
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number500-P105-1MG
Antibody TypePrimary
ClonalityPolyclonal
ReactivityHuman
FormatPBS with no preservative
ApplicationsELISA, Western Blot
ImmunogenE.coli-derived Recombinant Human GRO-gamma (CXCL3)
TargetCXCL3
Conjugate/TagUnconjugated
HostRabbit
Quantity1 mg
PurityAntigen affinity chromatography
Concentration0.1-1.0 mg/mL
NCBI Full Gene NameC-X-C motif chemokine ligand 3
NCBI Gene AliasesCINC-2b, GRO3, GROg, MIP-2b, MIP2B, SCYB3
Storage-20°C

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) NAP-2 Secreted by Human NK Cells Can Stimulate Mesenchymal Stem/Stromal Cell RecruitmentStem cell reportsApril 12, 2016Almeida CR, Caires HR, Vasconcelos DP, Barbosa MA.

(2) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosisClinical cancer research : an official journal of the American Association for Cancer ResearchFebruary 1, 2003White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg DA.

(3) The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma"Journal of immunology (Baltimore, Md. : 1950)"January 1, 0001"Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM."

Be the First to Write a Review!